These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 19373559)
1. Recent advances in using Drosophila to model neurodegenerative diseases. Lu B Apoptosis; 2009 Aug; 14(8):1008-20. PubMed ID: 19373559 [TBL] [Abstract][Full Text] [Related]
2. Drosophila models of neurodegenerative diseases. Lu B; Vogel H Annu Rev Pathol; 2009; 4():315-42. PubMed ID: 18842101 [TBL] [Abstract][Full Text] [Related]
3. Drosophila as a screening tool to study human neurodegenerative diseases. Lenz S; Karsten P; Schulz JB; Voigt A J Neurochem; 2013 Nov; 127(4):453-60. PubMed ID: 24028575 [TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration: RNA turns number one suspect in polyglutamine diseases. Birman S Curr Biol; 2008 Aug; 18(15):R659-R661. PubMed ID: 18682207 [TBL] [Abstract][Full Text] [Related]
5. Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Lawlor KT; O'Keefe LV; Samaraweera SE; van Eyk CL; McLeod CJ; Maloney CA; Dang TH; Suter CM; Richards RI Hum Mol Genet; 2011 Oct; 20(19):3757-68. PubMed ID: 21724553 [TBL] [Abstract][Full Text] [Related]
6. Modeling Neurodegenerative Disorders in Bolus H; Crocker K; Boekhoff-Falk G; Chtarbanova S Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357532 [No Abstract] [Full Text] [Related]
7. A functional misexpression screen uncovers a role for enabled in progressive neurodegeneration. Rezával C; Berni J; Gorostiza EA; Werbajh S; Fagilde MM; Fernández MP; Beckwith EJ; Aranovich EJ; Sabio y García CA; Ceriani MF PLoS One; 2008 Oct; 3(10):e3332. PubMed ID: 18841196 [TBL] [Abstract][Full Text] [Related]
8. Time is of the essence: microRNAs and age-associated neurodegeneration. Aw S; Cohen SM Cell Res; 2012 Aug; 22(8):1218-20. PubMed ID: 22491478 [TBL] [Abstract][Full Text] [Related]
9. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. McLeod CJ; O'Keefe LV; Richards RI Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976 [TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases? Kretzschmar D Invert Neurosci; 2005 Nov; 5(3-4):97-109. PubMed ID: 16187075 [TBL] [Abstract][Full Text] [Related]
11. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases. Ghosh S; Feany MB Hum Mol Genet; 2004 Sep; 13(18):2011-8. PubMed ID: 15254017 [TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders. Krench M; Littleton JT Curr Top Dev Biol; 2017; 121():201-223. PubMed ID: 28057300 [TBL] [Abstract][Full Text] [Related]
13. Invertebrate models of lysosomal storage disease: what have we learned so far? Hindle S; Hebbar S; Sweeney ST Invert Neurosci; 2011 Dec; 11(2):59-71. PubMed ID: 22038288 [TBL] [Abstract][Full Text] [Related]
15. Drosophila: a "model" model system to study neurodegeneration. Celotto AM; Palladino MJ Mol Interv; 2005 Oct; 5(5):292-303. PubMed ID: 16249525 [TBL] [Abstract][Full Text] [Related]
18. RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila. Langellotti S; Romano G; Feiguin F; Baralle FE; Romano M PLoS One; 2018; 13(4):e0195845. PubMed ID: 29652933 [TBL] [Abstract][Full Text] [Related]
19. Human neurodegenerative disease modeling using Drosophila. Bonini NM; Fortini ME Annu Rev Neurosci; 2003; 26():627-56. PubMed ID: 12704223 [TBL] [Abstract][Full Text] [Related]
20. Drosophila models of neurodegenerative disease. Sang TK; Jackson GR NeuroRx; 2005 Jul; 2(3):438-46. PubMed ID: 16389307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]